Synth Finance Logo Logo API

Estrella Immunopharma, Inc. - Warrant (ESLAW) logo

PNG 1.92 KB
Download
https://logo.synthfinance.com/ticker/ESLAW
HTML
<img src="https://logo.synthfinance.com/ticker/ESLAW" />
About Estrella Immunopharma, Inc. - Warrant (ESLAW)

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Industry

Biotechnology

Sector

Healthcare